USANA Full Year Net Sales Rise 5 Percent to 1.186 Billion

USANA Health Sciences said fiscal 2021 net sales rose 5 percent to 1.186 billion dollars and diluted earnings per share were 5.73 dollars. Fourth-quarter net sales were 267.3 million dollars, down 14 percent, and diluted earnings per share were 1.03 dollars. Fiscal 2020 was a 53-week year, and the company said the extra week added about 18 million dollars of sales and an estimated 17 cents of earnings per share to the prior-year comparisons. Active customers were 560,000, down 7 percent.

Chief executive and chairman Kevin Guest said Asia Pacific COVID restrictions and lower gross margin weighed on the fourth quarter. The company introduced 2022 guidance of 1.125 billion to 1.225 billion dollars in net sales and 5.25 to 6.00 dollars in diluted earnings per share. It ended the year with 240 million dollars in cash and no debt after buying back 296,000 shares for 28.9 million dollars in the fourth quarter.